Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3362)
All Articles published online
|
Mar 14, 2006 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiang PH, Motoo Y, Sawabu N, Minamoto T. Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells. World J Gastroenterol 2006; 12(10): 1597-1602 [PMID: 16570353 DOI: 10.3748/wjg.v12.i10.1597] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i10/1597.htm |
| Number | Citing Articles |
| 1 |
Btissame El Hassouni, Giovanna Li Petri, Daniel S.K. Liu, Stella Cascioferro, Barbara Parrino, Waqar Hassan, Patrizia Diana, Asif Ali, Adam E Frampton, Elisa Giovannetti. Pharmacogenetics of treatments for pancreatic cancer. Expert Opinion on Drug Metabolism & Toxicology 2019; 15(6): 437 doi: 10.1080/17425255.2019.1620731
|
| 2 |
Heidar Moradnia, Heidar Raissi, Mahnaz Shahabi. The performance of the single-walled carbon nanotube covalently modified with polyethylene glycol to delivery of Gemcitabine anticancer drug in the aqueous environment. Journal of Biomolecular Structure and Dynamics 2021; 39(3): 881 doi: 10.1080/07391102.2020.1719204
|
| 3 |
Zahra Najafi rad, Farzaneh Farzad, Leila Razavi. Surface functionalization of graphene nanosheet with poly (l-histidine) and its application in drug delivery: covalent vs non-covalent approaches. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21619-0
|
| 4 |
Bart Kramer, Luuk de Haan, Marjolein Vermeer, Thomas Olivier, Thomas Hankemeier, Paul Vulto, Jos Joore, Henriëtte L. Lanz. Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins. International Journal of Molecular Sciences 2019; 20(18): 4647 doi: 10.3390/ijms20184647
|
| 5 |
Xu Ying, Li Jing, Shijie Ma, Qianjun Li, Xiaoling Luo, Zhenguo Pan, Yanling Feng, Pan Feng. GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0216-y
|
| 6 |
Yixing Jiang, Nicole A. DiVittore, James M. Kaiser, Sriram S. Shanmugavelandy, Jennifer L. Fritz, Yasser Heakal, Hephzibah Rani S. Tagaram, Hua Cheng, Myles C. Cabot, Kevin F. Staveley-O'Carroll, Melissa A. Tran, Todd E. Fox, Brian M. Barth, Mark Kester. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biology & Therapy 2011; 12(7): 574 doi: 10.4161/cbt.12.7.15971
|
| 7 |
Jun Lu, Xiaowu Wu, Amira Hassouna, Kelvin Wang, Yan Li, Tao Feng, Yu Zhao, Minfeng Jin, Baohong Zhang, Tianlei Ying, Jinyao Li, Lufeng Cheng, Johnson Liu, Yue Huang. Gemcitabine‑fucoxanthin combination in human pancreatic cancer cells. Biomedical Reports 2023; 19(1) doi: 10.3892/br.2023.1629
|
| 8 |
Anna Leja-Szpak, Jolanta Jaworek, Piotr Pierzchalski, Russel J. Reiter. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). Journal of Pineal Research 2010; 49(3): 248 doi: 10.1111/j.1600-079X.2010.00789.x
|
| 9 |
Linda Waldherr, Maria Seitanidou, Marie Jakešová, Verena Handl, Sophie Honeder, Marta Nowakowska, Tamara Tomin, Meysam Karami Rad, Tony Schmidt, Joachim Distl, Ruth Birner‐Gruenberger, Gord von Campe, Ute Schäfer, Magnus Berggren, Beate Rinner, Martin Asslaber, Nassim Ghaffari‐Tabrizi‐Wizsy, Silke Patz, Daniel T. Simon, Rainer Schindl. Targeted Chemotherapy of Glioblastoma Spheroids with an Iontronic Pump. Advanced Materials Technologies 2021; 6(5) doi: 10.1002/admt.202001302
|
| 10 |
Qi-sheng Xia, Yasuhito Ishigaki, Xia Zhao, Takeo Shimasaki, Hideo Nakajima, Hideaki Nakagawa, Tsutomu Takegami, Zhi-hua Chen, Yoshiharu Motoo. Human SMG-1 is Involved in Gemcitabine-Induced Primary microRNA-155/BIC Up-Regulation in Human Pancreatic Cancer PANC-1 Cells. Pancreas 2011; 40(1): 55 doi: 10.1097/MPA.0b013e3181e89f74
|
| 11 |
Nelson S. Yee, Weiqiang Zhou, Minsun Lee, Rosemary K. Yee. Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma. Cancer Letters 2012; 318(1): 99 doi: 10.1016/j.canlet.2011.12.007
|
| 12 |
Takafumi Kuroda, Hideaki Ogiwara, Mariko Sasaki, Kazuaki Takahashi, Hiroshi Yoshida, Takako Kiyokawa, Kazuki Sudo, Kenji Tamura, Tomoyasu Kato, Aikou Okamoto, Takashi Kohno. Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma. Gynecologic Oncology 2019; 155(3): 489 doi: 10.1016/j.ygyno.2019.10.002
|
| 13 |
Manabu Mikamori, Daisaku Yamada, Hidetoshi Eguchi, Shinichiro Hasegawa, Tomoya Kishimoto, Yoshito Tomimaru, Tadafumi Asaoka, Takehiro Noda, Hiroshi Wada, Koichi Kawamoto, Kunihito Gotoh, Yutaka Takeda, Masahiro Tanemura, Masaki Mori, Yuichiro Doki. MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/srep42339
|
| 14 |
Patricia Santofimia-Castaño, Juan Iovanna. Combating pancreatic cancer chemoresistance by triggering multiple cell death pathways. Pancreatology 2021; 21(3): 522 doi: 10.1016/j.pan.2021.01.010
|
| 15 |
Xin-yu Huang, Hong-cheng Wang, Zhou Yuan, Ang Li, Mei-lan He, Kai-xing Ai, Qi Zheng, Huan-long Qin. Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells. Acta Pharmacologica Sinica 2010; 31(6): 741 doi: 10.1038/aps.2010.54
|
| 16 |
Sugata Barui, Marzia Conte, Nicolò Maria Percivalle, Rocío María García Montero, Luisa Racca, Marco Allione, Valentina Cauda. Dual Drug Loaded Nanotheranostic Platforms as a Novel Synergistic Approach to Improve Pancreatic Cancer Treatment. Particle & Particle Systems Characterization 2023; 40(4) doi: 10.1002/ppsc.202200138
|
| 17 |
Catherine Burkhart, Daria Fleyshman, Rachael Kohrn, Mairead Commane, Jennifer Garrigan, Vadim Kurbatov, Ilya Toshkov, Rajesh Ramachandran, Laura Martello, Katerina V. Gurova. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer. Oncotarget 2014; 5(22): 11038 doi: 10.18632/oncotarget.2701
|
| 18 |
D. Taïeb, S. Giusiano, F. Sebag, M. Marcy, C. de Micco, F. F. Palazzo, N. J. Dusetti, J. L. Iovanna, J. F. Henry, S. Garcia, Colette Taranger‐Charpin. Tumor Protein p53‐Induced Nuclear Protein (TP53INP1) Expression in Medullary Thyroid Carcinoma: A Molecular Guide to the Optimal Extent of Surgery?. World Journal of Surgery 2010; 34(4): 830 doi: 10.1007/s00268-010-0395-6
|
| 19 |
Verena Handl, Linda Waldherr, Theresia Arbring Sjöström, Tobias Abrahamsson, Maria Seitanidou, Sabine Erschen, Astrid Gorischek, Iwona Bernacka-Wojcik, Helena Saarela, Tamara Tomin, Sophie Elisabeth Honeder, Joachim Distl, Waltraud Huber, Martin Asslaber, Ruth Birner-Grünberger, Ute Schäfer, Magnus Berggren, Rainer Schindl, Silke Patz, Daniel T. Simon, Nassim Ghaffari-Tabrizi-Wizsy. Continuous iontronic chemotherapy reduces brain tumor growth in embryonic avian in vivo models. Journal of Controlled Release 2024; 369: 668 doi: 10.1016/j.jconrel.2024.03.044
|
| 20 |
Qian Wei, Yi‐Xuan Li, Min Liu, Xin Li, Hua Tang. MiR‐17‐5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life 2012; 64(8): 697 doi: 10.1002/iub.1051
|
| 21 |
Dina Aggad, Chiara Mauriello Jimenez, Soraya Dib, Jonas G. Croissant, Laure Lichon, Danielle Laurencin, Sébastien Richeter, Marie Maynadier, Shahad K. Alsaiari, Makhlouf Boufatit, Laurence Raehm, Marcel Garcia, Niveen M. Khashab, Magali Gary‐Bobo, Jean‐Olivier Durand. Gemcitabine Delivery and Photodynamic Therapy in Cancer Cells via Porphyrin‐Ethylene‐Based Periodic Mesoporous Organosilica Nanoparticles. ChemNanoMat 2018; 4(1): 46 doi: 10.1002/cnma.201700264
|
| 22 |
|
| 23 |
Mallaredy Vandana, Sanjeeb K. Sahoo. Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer. Biomaterials 2010; 31(35): 9340 doi: 10.1016/j.biomaterials.2010.08.010
|
| 24 |
NAOKI NAKAYA, YASUHITO ISHIGAKI, HIDEO NAKAJIMA, MANABU MURAKAMI, TAKEO SHIMASAKI, TAKANOBU TAKATA, MAMORU OZAKI, NELSON J. DUSETTI, JUAN L. IOVANNA, YOSHIHARU MOTOO. Meaning of tumor protein 53-induced nuclear protein 1 in the molecular mechanism of gemcitabine sensitivity. Molecular and Clinical Oncology 2013; 1(1): 100 doi: 10.3892/mco.2012.8
|
| 25 |
Houda Saadi, Marion Seillier, Alice Carrier. The stress protein TP53INP1 plays a tumor suppressive role by regulating metabolic homeostasis. Biochimie 2015; 118: 44 doi: 10.1016/j.biochi.2015.07.024
|
| 26 |
Thierry Voisin, Pascal Nicole, Valérie Gratio, Anaïs Chassac, Dounia Mansour, Vinciane Rebours, Anne Couvelard, Alain Couvineau. The Orexin-A/OX1R System Induces Cell Death in Pancreatic Cancer Cells Resistant to Gemcitabine and Nab-Paclitaxel Treatment. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.904327
|
| 27 |
Shuhei Kawasaki, Hideo Ohtsuka, Yoshihiro Sato, Daisuke Douchi, Masaki Sato, Kyohei Ariake, Kunihiro Masuda, Koji Fukase, Masamichi Mizuma, Kei Nakagawa, Hiroki Hayashi, Takanori Morikawa, Fuyuhiko Motoi, Michiaki Unno. Silencing of LRRFIP1 enhances the sensitivity of gemcitabine in pancreatic cancer cells by activating JNK/c-Jun signaling. Pancreatology 2021; 21(4): 771 doi: 10.1016/j.pan.2021.02.018
|
| 28 |
Anna K. Laskowska, Anna K. Puszko, Piotr Sosnowski, Krzysztof Różycki, Piotr Kosson, Joanna Matalińska, Marek Durlik, Aleksandra Misicka. Opioid Tripeptides Hybridized with trans‐1‐Cinnamylpiperazine as Proliferation Inhibitors of Pancreatic Cancer Cells in Two‐ and Three‐Dimensional in vitro Models. ChemMedChem 2017; 12(19): 1637 doi: 10.1002/cmdc.201700453
|
| 29 |
Takeo Shimasaki, Yasuhito Ishigaki, Yuka Nakamura, Takanobu Takata, Naoki Nakaya, Hideo Nakajima, Itaru Sato, Xia Zhao, Ayako Kitano, Kazuyuki Kawakami, Takuji Tanaka, Tsutomu Takegami, Naohisa Tomosugi, Toshinari Minamoto, Yoshiharu Motoo. Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. Journal of Gastroenterology 2012; 47(3): 321 doi: 10.1007/s00535-011-0484-9
|
| 30 |
Kai Masur, Magdalena von Behr, Sander Bekeschus, Klaus‐Dieter Weltmann, Christine Hackbarth, Claus‐Dieter Heidecke, Wolfram von Bernstorff, Thomas von Woedtke, Lars Ivo Partecke. Synergistic Inhibition of Tumor Cell Proliferation by Cold Plasma and Gemcitabine. Plasma Processes and Polymers 2015; 12(12): 1377 doi: 10.1002/ppap.201500123
|
| 31 |
Navin Sarin, Florian Engel, Ganna V. Kalayda, Mareike Mannewitz, Jindrich Cinatl, Florian Rothweiler, Martin Michaelis, Hisham Saafan, Christoph A. Ritter, Ulrich Jaehde, Roland Frötschl, Aamir Ahmad. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest. PLOS ONE 2017; 12(7): e0181081 doi: 10.1371/journal.pone.0181081
|
| 32 |
Julien Gommeaux, Carla Cano, Stéphane Garcia, Meritxell Gironella, Sylvia Pietri, Marcel Culcasi, Marie-Josèphe Pébusque, Bernard Malissen, Nelson Dusetti, Juan Iovanna, Alice Carrier. Colitis and Colitis-Associated Cancer Are Exacerbated in Mice Deficient for Tumor Protein 53-Induced Nuclear Protein 1. Molecular and Cellular Biology 2007; 27(6): 2215 doi: 10.1128/MCB.01454-06
|